Comparison of the effect of ketamine and magnesium sulfate on acute asthma attack
Phase 3
- Conditions
- asthma.
- Registration Number
- IRCT20200914048715N1
- Lead Sponsor
- -
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
age<65
age<>18
Corticosteroid-resistant asthma attack
No history of allergy to ketamine or sulfamide
Exclusion Criteria
Dissatisfaction with participating in the study
age<18
age>65
weight>40
Drug or alcohol poisoning
Active psychiatric illness
History of ketamine allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of treatment - Hospitalization requirement - Acute refractory asthma attack - PEFR. Timepoint: 0-30-60 MIN. Method of measurement: Ketamine protocol - number of patients admitted - peak flowmetry.
- Secondary Outcome Measures
Name Time Method -. Timepoint: -. Method of measurement: -.